(Q43772908)

26 November 2017

title

A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

26 November 2017

main subject

0 references

4

Petri M

1 reference

26 November 2017

Ho A

1

1 reference

26 November 2017

Barr SG

series ordinal

2

1 reference

26 November 2017

Magder LS

series ordinal

3

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

published in

Arthritis & Rheumatology

1 reference

26 November 2017

volume

44

1 reference

26 November 2017

issue

10

1 reference

26 November 2017

page(s)

2350-2357

1 reference

Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Longitudinal data analysis for discrete and continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Immunologic factors and clinical activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Glomerular Complement Components in Human Glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Ro (SS-A) antibody and antigen in a patient with congenital complete heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Complement in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200110%2944%3A10%3C2350%3A%3AAID-ART398%3E3.0.CO%3B2-A

10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference